)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Altamira Therapeutics (CYTO) investor relations material
Altamira Therapeutics H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary29 Aug, 2025
Executive summary
Strategic shift to focus on RNA delivery business, with a planned partial spin-off of the Swiss subsidiary ATAG to attract private equity investment and transform the parent into a holding company.
Expanded RNA delivery client base and advanced the xPhore platform, including new Cyclophore technology for circular RNA applications.
Legacy assets, including Bentrio nasal spray and AM-125/AM-111, are being monetized or transitioned, with progress in manufacturing and regulatory approvals.
Continued cost structure adjustments and furthered development of legacy assets, including Bentrio and AM-125.
Financial highlights
Operating loss for H1 2025 was $2.6 million, down 32.9% year-over-year, driven by lower G&A and R&D expenses.
Net loss decreased 64.6% to $1.5 million, aided by $1.7 million in finance income from currency appreciation.
Cash used in operations dropped 56.8% to $1.4 million; cash and equivalents at June 30, 2025, were $4,000.
Shareholders’ equity was $4.1 million at mid-2025, down from $6.6 million at year-end 2024.
Basic and diluted loss per share for H1 2025 was $(0.31), compared to $(2.11) in H1 2024.
Outlook and guidance
Anticipates significant reduction in operating expenses post-spin-off of ATAG.
Funding expected from cash, sale of ATAG shares, legacy asset monetization, and service provision.
Financial guidance will be updated as material developments occur, especially regarding the spin-off.
Altamira's funding post-ATAG spin-off?
Impact of new circular RNA partnership?
Bentrio's EU commercialization hurdles?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Altamira Therapeutics earnings date
H2 202529 Apr, 2026
Next Altamira Therapeutics earnings date
H2 202529 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Altamira Therapeutics Ltd is a Switzerland-based biopharmaceutical company focused on developing and commercializing therapies for ear, nose, and throat (ENT) and central nervous system (CNS) disorders. The company's pipeline includes RNA-based therapeutics, as well as treatments for inner ear conditions such as tinnitus and vertigo. Altamira Therapeutics applies its proprietary delivery platforms to target therapeutic molecules effectively, aiming to address unmet medical needs across its key treatment areas. The company is headquartered in Hamilton, Bermuda, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage